Yes. Most people can live a normal lifespan with one carotid artery, because the two vertebral arteries and the contralateral carotid can supply both hemispheres through the circle of Willis. Roughly 5 to 15 percent of adults already have at least one carotid that is completely occluded, and many of them never knew.
How the brain tolerates losing one carotid
The carotid system delivers about 70 to 80 percent of cerebral blood flow, with each internal carotid carrying roughly 250 to 350 milliliters per minute in a healthy adult. The vertebral arteries contribute the remainder, about 150 to 200 milliliters per minute combined. When one internal carotid disappears, total flow to the brain drops on paper by a third or more, yet measured deficits are usually far smaller.
The reason is autoregulation. Cerebral arterioles constrict and dilate to hold flow near 50 milliliters per 100 grams of tissue per minute across a mean arterial pressure range of roughly 60 to 150 millimeters of mercury. Within minutes of a carotid occlusion, downstream vessels dilate to recruit collateral flow. Over weeks, the circle of Willis and leptomeningeal connections remodel, and the vessel caliber of the remaining arteries can increase.
The circle of Willis is the critical junction. A complete polygon connects the two internal carotids through the anterior communicating artery and links each carotid to the posterior circulation through the posterior communicating arteries. Complete circles appear in only about 20 to 45 percent of people, depending on imaging series. The rest have at least one hypoplastic or absent segment, which shifts the collateral burden to smaller surface vessels.
A second buffer is the external carotid artery. Its branches, including the ophthalmic and facial arteries, form anastomoses with the internal carotid territory in some people. When the internal carotid occludes slowly, these channels enlarge over months and supply the eye and deep brain regions retrograde. This explains why a gradual occlusion often produces no stroke while a sudden one can.
The mechanism of harm, when it occurs, is usually embolic rather than purely flow-related. A narrowed carotid generates turbulent shear stress at the plaque, and platelet aggregates break off and travel to the middle cerebral artery. Flow-limiting lesions cause a second pattern, border-zone infarcts in the watershed between the anterior and middle cerebral artery territories. Removing one artery changes the geometry of both risks.
Quantified context: how often, how much, and how risky
Complete internal carotid occlusion accounts for an estimated 6 to 15 percent of ischemic strokes in large stroke registries, and about 15 to 25 percent of transient ischemic attacks in older adults are attributed to carotid disease. Population screening studies find asymptomatic internal carotid occlusion in roughly 1 percent of adults over 65, and severe stenosis above 70 percent in 3 to 5 percent.
The natural history depends heavily on symptoms. Among people with a recently symptomatic severe stenosis, the risk of recurrent ipsilateral stroke is roughly 15 to 20 percent within two years without intervention. Among those with asymptomatic severe stenosis, the annual stroke risk on medical therapy alone sits near 1 to 2 percent per year in modern cohorts, lower than the 2 to 4 percent rates reported in older trials.
When one carotid is already occluded, the remaining artery carries a higher velocity and a higher wall shear stress. Studies of contralateral stenosis in this setting report annual ipsilateral stroke risk of about 3 to 5 percent when the remaining vessel is severely narrowed, versus under 1 percent when it is normal. That gradient is why the surviving carotid becomes the focus of surveillance.
Blood pressure matters more than most people expect. The brain with a single carotid has less reserve to tolerate hypotension, and nocturnal dips below about 90 millimeters of mercury systolic can provoke border-zone ischemia in a minority of patients with poor collaterals. Conversely, aggressive lowering in the first days after an acute occlusion can worsen perfusion in the vulnerable hemisphere.
Comparison: management options when one carotid is gone
| Situation | Typical approach | Key threshold | Trade-off |
|---|---|---|---|
| Asymptomatic occlusion, good collaterals | Antiplatelet therapy plus risk-factor control | No intervention | Avoids procedural risk; requires monitoring |
| Symptomatic occlusion within 2 weeks | Medical optimization, selective revascularization in specialized centers | Recurrent symptoms despite therapy | High procedural risk; limited evidence |
| Contralateral stenosis above 70 percent, asymptomatic | Consider revascularization in low-risk patients | 70 percent by angiography | Stroke reduction versus procedure risk |
| Contralateral stenosis above 50 percent, symptomatic | Revascularization generally favored | 50 percent symptomatic | Clear benefit in recent trials |
| Poor collateral reserve on imaging | Intensive pressure management, avoid hypotension | Impaired cerebrovascular reserve | No proven surgical fix |
| Acute occlusion with stroke | Thrombolysis or thrombectomy if eligible | Within 4.5 to 24 hours depending on criteria | Time-critical; not for everyone |
Timeline: what happens after a carotid is lost
| Time frame | Physiologic event | Clinical implication |
|---|---|---|
| Seconds to minutes | Flow drop, autoregulatory dilation | Silent in most; dizziness or transient deficit in some |
| Hours | Collateral recruitment begins | Border-zone risk if hypotensive |
| Days 1 to 7 | Edema and reperfusion changes | Highest early stroke risk after a symptomatic event |
| Weeks 2 to 8 | Collateral vessel remodeling | Symptoms stabilize in most patients |
| Months 3 to 12 | Circle of Willis caliber increases | Functional capacity improves |
| Year 1 onward | Stable compensated state | Annual stroke risk near 1 to 2 percent with good control |
Edge cases that change the answer
Age at occlusion matters. Children and young adults remodel collateral vessels more robustly than people over 75, whose baseline collateral density is lower and whose autoregulatory range is narrower. A 40-year-old with a single carotid often has no measurable deficit on cognitive testing, while an 80-year-old may show slowed processing speed and gait instability.
Bilateral disease is the harder scenario. Roughly 5 to 10 percent of people with one occluded carotid have significant stenosis in the other. When both are severely diseased, the brain depends on the vertebral arteries, and blood pressure becomes the single most important variable. Some patients in this group need permissive hypertension rather than tight control.
Cognitive effects are subtle but real. Imaging studies of people with chronic carotid occlusion show reduced cerebrovascular reactivity in the affected hemisphere, and some cohorts report mild deficits in attention and processing speed. These findings are inconsistent and do not translate to dementia in most patients. The counterintuitive detail is that cognitive scores often improve after successful revascularization of the contralateral artery, not the occluded one.
A professional caveat: a single carotid can be entirely compatible with normal life, but the phrase normal life hides a conditional. The compensation depends on pressure stability, on the remaining vessel staying clean, and on the absence of a cardiac source of emboli. A person with one carotid and untreated atrial fibrillation faces a different risk than one with a clean contralateral artery.
Misconceptions worth correcting
The first misconception is that losing one carotid halves brain blood supply. It does not. Autoregulation and collateral recruitment restore flow to near baseline in most people, and total cerebral blood flow typically falls by 10 to 20 percent, not 50.
The second is that a single carotid means a guaranteed stroke. It does not. Modern cohorts with good blood pressure control, antiplatelet therapy, and statin use show annual stroke rates near 1 percent for many patients with chronic occlusion. The risk is elevated but manageable.
The third is that the remaining artery will simply wear out. It does carry higher flow, but longitudinal studies do not show accelerated atherosclerosis attributable to that alone. The dominant driver remains the same: smoking, diabetes, hypertension, and dyslipidemia.
The fourth is that surgery can fix an occluded carotid. Reopening a chronically occluded internal carotid is technically difficult, rarely attempted, and not standard care. The focus shifts to protecting the contralateral side and the posterior circulation.
Red-flag warnings that warrant urgent evaluation:
Sudden weakness, numbness, or speech difficulty on either side, especially if it resolves within minutes. New transient monocular blindness, a curtain over one eye lasting seconds to minutes. A new severe headache with neck pain after any neck manipulation or trauma. Progressive dizziness, double vision, or gait instability over hours.
Practical actions and thresholds
Step one is confirm the anatomy. Carotid duplex ultrasound reports peak systolic velocity, and a velocity above 125 centimeters per second in the internal carotid suggests stenosis of 50 percent or more, while above 230 centimeters per second suggests 70 percent or more. Confirm with computed tomography angiography or magnetic resonance angiography before any decision.
Step two is protect the surviving artery. Target blood pressure below 130 over 80 millimeters of mercury in most adults, but individualize upward if symptoms occur with dips. Use high-intensity statin therapy when the remaining vessel shows plaque, and maintain antiplatelet therapy as directed. Smoking cessation is the single highest-yield intervention, cutting recurrent vascular events by roughly half within two years.
Step three is surveillance. Repeat duplex ultrasound every 6 to 12 months for the first two years after an occlusion, then annually if stable. Escalate to angiography if velocities rise by more than 30 percent or if new symptoms appear.
Step four is pressure discipline during illness. Dehydration, fever, and surgery can all cause hypotension. Patients with a single carotid should discuss a lower acceptable blood pressure limit with their clinician before elective procedures. A commonly cited floor is 100 millimeters of mercury systolic, though this is individualized.
Step five is know the time thresholds for acute care. Intravenous thrombolysis is generally considered within 4.5 hours of symptom onset, and thrombectomy within 6 hours in most cases, extending to 24 hours in selected patients with imaging criteria. Time to treatment drives outcomes more than any single anatomic feature.
Step six is address the other side. If contralateral stenosis exceeds 70 percent and the patient is a reasonable procedural candidate, revascularization reduces ipsilateral stroke risk by roughly half over five years in trial data. Discuss the trade-off explicitly with a vascular specialist.
Limitations of the evidence
Most of what is known comes from observational cohorts rather than randomized trials, because randomizing people to keep or lose a carotid is not ethical. The largest trial evidence addresses stenosis management, not occlusion itself. Estimates of annual stroke risk in chronic occlusion therefore carry wide confidence intervals.
Imaging of collateral status is not standardized. Cerebrovascular reserve testing with acetazolamide or carbon dioxide challenge identifies impaired hemispheres, but no trial has shown that acting on those results changes outcomes. The test informs risk but not proven therapy.
Cognitive and quality-of-life data are sparse and heterogeneous. Some studies find no difference; others find subtle deficits. The honest position is that long-term brain function with one carotid is usually preserved, but the evidence base for that claim is thinner than the confidence with which it is often stated.
The bottom line is conditional but clear. A single carotid is compatible with a long, active life when the remaining vessel is protected, pressure is stable, and symptoms are recognized early. The patients who struggle are those with bilateral disease, poor collaterals, or uncontrolled vascular risk factors. For everyone else, the body has already solved the problem through mechanisms that predate the diagnosis.